Skip to main content
Clinical Trials/NCT04537728
NCT04537728CompletedNot Applicable

My Healthy Brain: Preserving and Promoting Brain Health Through Evidence-based Practices

Massachusetts General Hospital1 site in 1 country11 target enrollmentStarted: September 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
11
Locations
1
Primary Endpoint
Recruitment Feasibility

Study Overview

Brief Summary

The objective of this trial is to demonstrate early proof-of-concept for My Healthy Brain, an 8-week group program that directly targets multiple lifestyle factors associated with brain health and prevention of cognitive decline. The investigators will explore the feasibility, acceptability, and effect sizes of improvement in primary lifestyle outcomes as well as secondary outcomes of self-determination and subjective well-being.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
60 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age ≥ 60 years
  • English fluency/literacy
  • ≥1 modifiable brain disease risk factor (outlined by JAMA)
  • Bluetooth 4.0 enabled smartphone

Exclusion Criteria

  • Diagnosis of dementia; Montreal Cognitive Assessment < 18
  • Serious medical illness expected to worsen in next 6 months
  • Current suicidal ideation
  • Substance abuse
  • Untreated serious mental health conditions
  • Current use of digital monitoring device (eg. Fitbit)
  • Mindfulness practice (> 45 minutes/week) in the last three months

Arms & Interventions

My Healthy Brain Version 2

Experimental

an 8-week group program that directly targets multiple lifestyle factors associated with brain health and prevention of CD

Intervention: My Healthy Brain Version 2 (Behavioral)

Outcomes

Primary Outcomes

Recruitment Feasibility

Time Frame: Baseline (0 Weeks)

percent of referred patients meeting criteria to participate

Credibility and Expectancy Questionnaire (CEQ)

Time Frame: Baseline (0 Weeks)

percent of participants that score beyond scale midpoint

Treatment Fidelity

Time Frame: Baseline (0 Weeks), Post-Test (8 Weeks)

percent of sessions rated as 100% adherent

Assessment Feasibility

Time Frame: Baseline (0 Weeks), Post-Test (8 Weeks)

percent of post-questionnaires completed

Client Satisfaction Questionnaire (CSQ-3)

Time Frame: Baseline (0 Weeks), Post-Test (8 Weeks)

Items are summed to generate a total score; scores range from 3 to 12, with higher values indicating higher satisfaction.

Program Acceptability

Time Frame: Baseline (0 Weeks), Post-Test (8 Weeks)

percent of participants completing at least 6 sessions

Adherence to Actigraph

Time Frame: Baseline (0 Weeks), Post-Test (8 Weeks)

percent of participants wearing Actiwatch ≥ 5 days per week

Adherence to Lifestyle Behaviors

Time Frame: Baseline (0 Weeks), Post-Test (8 Weeks)

percent of participants completing weekly homework

Secondary Outcomes

  • Physical Activity: Rapid Assessment of Physical Activity(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Nutrition: MIND Diet Adherence Checklist(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Nutrition: Mediterranean Eating Pattern for Americans Screener(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Medication and Substance Use: Alcohol Use Disorders Identification Test-Consumption(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Medication and Substance Use: Fagerstrom Test for Nicotine Depedence(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Social Functioning: PROMIS Emotional Support(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Mindfulness: Cognitive and Affective Mindfulness Scale(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Sleep: Pittsburgh Sleep Quality Index(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Stress and Emotional Functioning: PROMIS Depression(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Physical Activity: Godin Leisure Time Exercise Questionnaire(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Medication and Substance Use: Morisky Medication Adherence Scale(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Social Functioning: UCLA Loneliness Scale(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Mindfulness: Five-Facet Mindfulness Questionnaire(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Change in Healthy Aging(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Mindfulness: Homework log(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Physical Activity: Actigraph measures of activity(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Stress and Emotional Functioning: Perceived Stress Scale(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Social Functioning: PROMIS Social Isolation(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Cognitive Functioning: Everyday Cognition Scale(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Cognitive Functioning: PROMIS Cognition(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Cognitive Functioning: Montreal Cognitive Assessment(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Sleep: Jenkins Sleep Questionnaire(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Sleep: Actigraph measures of sleep(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Physical Activity: PROMIS Physical Function(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Stress and Emotional Functioning: Heart Rate Variability (Actigraphy)(Baseline (0 Weeks), Post-Test (8 Weeks))
  • Stress and Emotional Functioning: PROMIS Anxiety(Baseline (0 Weeks), Post-Test (8 Weeks))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ana-Maria Vranceanu, PhD

Principal Investigator

Massachusetts General Hospital

Study Sites (1)

Loading locations...

Similar Trials